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ABSTRAK
Penuaan ovari telah dikaitkan dengan tekanan oksidatif dan kehilangan fungsi 
ovari. Tokotrienol telah dibuktikan dapat memberi kesan yang baik terhadap sistem 
pembiakan wanita. Walau bagaimanapun, peranan tokotrienol ke atas metabolisma 
ovari dan seterusnya peningkatan kualiti oosit dalam mencit tua masih tidak 
diketahui. Oleh itu, hubungan antara perubahan aktiviti metabolik dalam ovari dan 
kualiti oosit dalam mencit tua selepas suplementasi fraksi kaya tokotrienol (TRF) 
telah dikaji. Mencit betina berusia enam minggu digunakan sebagai kumpulan 
Muda. Mencit betina berusia enam bulan dibahagikan kepada empat kumpulan 
iaitu kumpulan pertama yang diberikan minyak jagung-bebas tokoferol (kawalan) 
manakala tiga kumpulan yang lain diberi suplimen TRF pada dos 90, 120, dan 150 
mg/kg. Rawatan diberikan secara oral selama dua bulan. Pada akhir rawatan, mencit 
dari semua kumpulan disuperovulasi dan kemudian dikorbankan. Kualiti oosit 
dinilai dan analisis metabolomik secara tidak disasarkan, pada tisu ovari dijalankan 
dengan menggunakan 'liquid chromatography tandem mass spectrometry of 
quadrupole time-of-flight' (LC-MS Q-TOF). Peratusan oosit normal adalah lebih 
tinggi (p<0.001) manakala peratusan oosit yang tidak normal adalah lebih rendah 
(p<0.001) dalam kumpulan terawat dengan 150 mg/kg TRF berbanding dengan 
kawalan. Sebanyak 17 metabolit telah dikenal pasti menunjukkan perbezaan yang 
nyata dalam tisu ovari kumpulan Penuaan secara berbanding dengan kumpulan 
Muda. Selain itu, terdapat 14 metabolit yang menunjukkan perbezaan yang nyata 
antara kumpulan terawat TRF dengan kumpulan kawalan. Analisa tapak jalan 
menunjukkan perubahan tapak jalan  metabolik dalam metabolisma asid lemak 
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dan asid amino yang nyata berkemungkinan dapat mempengaruhi kualiti oosit. 
Kesimpulannya, suplementasi TRF dapat mengaruh perubahan metabolik dalam 
ovari yang dapat melambatkan kesan penuaan dan seterusnya meningkatkan 
kualiti oosit di dalam mencit tua.
Kata kunci: metabolomik, ovari, oosit, penuaan, tokotrienol
ABSTRACT
Ovarian aging has been associated with oxidative stress and loss of ovarian 
function. Tocotrienol has been proven to exert beneficial effects on the female 
reproductive system. However, the role of tocotrienol in affecting metabolism 
in the ovary and subsequently improving the quality of oocytes in aging mice 
remains unknown. Therefore, the relationship between metabolic changes in the 
ovary and the quality of oocytes in aging mice following tocotrienol-rich fraction 
(TRF) supplementation was investigated. Six-week-old female mice were used as 
the Young group. Six-month-old aged female mice were divided into four groups; 
the first group was given tocopherol-stripped corn oil (vehicle control) while the 
other three groups were supplemented with TRF at the dose of 90, 120, and 150 
mg/kg, respectively. The treatment was given orally for two months. At the end 
of the treatment, mice from all groups were superovulated and then euthanised. 
Oocyte quality was assessed and non-targeted metabolomic analysis of the ovarian 
tissues was performed using liquid chromatography-tandem mass spectrometry of 
quadrupole time-of-flight (LC-MS Q-TOF). Percentages of normal oocytes were 
higher (p<0.001) while abnormal oocytes were lower (p<0.001) in TRF 150 mg/kg 
group compared to that of the control. Seventeen metabolites were identified to 
be significantly different in the ovarian tissue of the aging group when compared 
to the young group. 14 metabolites were identified to be significantly different in 
the ovarian tissue between the control and TRF supplemented groups. Pathway 
analysis revealed significantly altered metabolic pathways for fatty acid and 
amino acid metabolism that might influence the quality of oocytes. In conclusion, 
TRF supplementation causes metabolic changes in the ovary that delay the 
consequences of aging, thus improving the quality of oocytes in aging mice. 
Keywords: aging, metabolomics, ovary, oocytes, tocotrienol
Statistics Malaysia 2018). Along with 
educational improvement and social 
changes, the age of marriage has been 
steadily rising to cause most women 
to delay childbearing (Mascarenhas et 
al. 2012). Therefore, aging is one of the 
INTRODUCTION
Over the past decade, female 
fertility is declining at an alarming 
rate in Malaysia as well as globally 
(Mascarenhas et al. 2012; Vital 
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factors for the reduction in fecundity 
as fertility diminishes in parallel with 
increasing age. Women lose their 
fertility in their middle age (around 35 
years old) and their fecundity expires 
soon thereafter (at more than 40 
years old) (Baird et al. 2005; Alviggi 
et al. 2009) fertility decreases with 
increasing maternal age. A slow but 
steady decrease in fertility is observed 
in women aged between 30 and 
35 years, which is followed by an 
accelerated decline among women 
aged over 35 years. A combination 
of delayed childbearing and reduced 
fecundity with increasing age has 
resulted in an increased number and 
proportion of women of greater than 
or equal to 35 years of age seeking 
assisted reproductive technology (ART). 
Eventually, ovarian aging may result in 
ovarian failure, leading to a decrease 
in follicle number and diminishes 
oocyte quality. It has been suggested 
that the loss of oocyte quality is due 
to an age-related increase in meiotic 
non-disjunction, causing an increased 
aneuploidy rate in the early embryo 
of females aged between 35-38 years. 
Mechanisms that may underlie the 
age-related decline in oocyte quality 
include possible differences between 
germ cells at the time of formation 
during fetal life, accumulated damage 
of oocytes and the changes in the 
quality of granulosa cells surrounding 
the oocyte (Broekmans et al. 2009)
followed by subsequent stages of overt 
cycle irregularity. The gradual decline 
in the size of the antral follicle cohort 
is best represented by decreasing 
levels of anti-Mullerian hormone. The 
variability of ovarian ageing among 
women is evident from the large 
variation in age at menopause. The 
identification of women who have 
severely decreased ovarian reserve 
for their age is clinically relevant. 
Ovarian reserve tests have appeared 
to be fairly accurate in predicting 
response to ovarian stimulation in the 
ART. As a result, women may possibly 
experience a loss in ovarian function 
by producing low quality oocytes and 
embryo leading to poor embryonic 
development. This could eventually 
lead to infertility, recurrent abortion, 
and aneuploidy.
 During aging, an imbalance between 
reactive oxygen species (ROS) and 
antioxidant systems occurs leading 
to oxidative stress, which negatively 
impacts reproductive processes such as 
ovulation, fertilization and embryonic 
development (Agarwal et al. 2006; 
Mohd Mutalip et al. 2018). Oocyte 
protection against ROS by antioxidants 
may play an important role in pre-
implantation embryonic development 
where it scavenges excessive ROS, 
thereby helping to maintain the 
oocyte’s oxidant/antioxidant balance. 
Khazaei et al. (2017) reported that the 
addition of antioxidant substances 
such as melatonin to in vitro 
maturation (IVM) media produced a 
cytoprotective effect on the cumulus-
oocyte complexes, thus supporting the 
subsequent embryonic development. 
Therefore, attenuation of oxidative 
stress by antioxidant supplementation 
could potentially reduce oxidative 
damage due to the aging process, thus 
maintaining the number and quality of 
oocytes and follicles in women (Liu et 
al. 2012; Wang et al. 2017) and also has 
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been implicated in reproductive aging. 
Telomere shortening is also involved 
in aging, and telomeres are particularly 
susceptible to ROS-induced damage. 
Previously, we had shown that 
antioxidant N-acetyl-L-cysteine (NAC). 
Tocotrienol, a component of natural 
vitamin E, was a potent antioxidant. 
Its molecular structure allows for more 
efficient penetration into tissues with 
saturated fatty layers, leading to the 
powerful disordering of membrane 
lipids and scavenging peroxyl radicals 
(Serbinova et al. 1991). According to 
Kanchi et al. (2017), tocotrienol as 
compared to tocopherol, exerts a more 
potent antioxidant activity in vitro and 
is more efficient in suppressing ROS 
levels. The antioxidant activity of palm 
oil derived tocotrienol-rich fraction 
(TRF) occurs through the inhibition of 
lipid peroxidation (Rajikin et al. 2012) 
and protein oxidation (Rajikin et al. 
(2012). There is increase in evidence 
of the beneficial effects of tocotrienol 
supplementation, especially in the 
female reproductive system. To date, 
several studies have demonstrated 
that following exposure to oxidative 
stress, TRF supplementation improves 
the quality of embryos and embryonic 
development (Hamdan et al. 2017; 
Nasibah et al. 2012) telomerase activity 
and oocytes qualities (morphology 
and deoxyribonucleic acid damage 
and preserves ovarian function (Saleh 
et al. 2015).
 Metabolomics is an emerging 
technology and has been widely used 
to identify biomarkers and to build 
metabolic profiles associated with 
biological activities and physiological 
status (Ke et al. 2015). In metabolomics 
analysis, it was shown that metabolic 
dysfunction is a common hallmark of 
the aging process. Studies describing 
the complete overview of metabolic 
changes related to the reproductive 
system in healthy aging mammals 
remains lacking. Analysis of ovarian 
metabolites would be useful to 
understand the biochemical changes 
that take place during aging and how 
it affects the quality of oocytes.
 Therefore, this study performed a 
metabolomics analysis in aging mice 
supplemented with TRF to identify 
the metabolites involved in female 
reproductive aging and infertility 
and also to elucidate the metabolic 
pathways which promote the protective 
effects of TRF as antioxidants.
MATERIALS AND METHODS
Materials
The following chemicals were 
obtained from the indicated source: 
tocopherol-stripped corn oil (MP 
Biomedicals, USA), and TRF palm 
oil (Sime Darby Bioganic Sdn Bhd, 
Malaysia). Tocotrienol-rich fraction 
palm oil per 100 g contained: 
α-tocotrienol (19.04%), β-tocotrienol 
(3.60%), γ-tocotrienol (21.12%), 
δ-tocotrienol (15.04%), α-tocopherol 
(17.11%) and olein (24.09%). TRF was 
diluted with tocopherol-stripped corn 
oil as a vehicle (Mokhtar et al. 2008) 
to obtain the desired concentrations 
of 90 mg/kg, 120 mg/kg and 150 mg/
kg body weight. Supplementation of 
TRF was administered by the force-
feeding technique (oral gavage) using 
a 20-gauge, 3.8 cm straight feeding 
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needle, with a smooth ball on the tip 
(Kent Scientific Corporation, USA). The 
dispensing volume was 0.1 ml. 
Method
Mice Feeding, Mating and 
Tocotrienol Supplementation 
The experimental protocol was in strict 
accordance with the regulations and 
prescribed animal ethical procedures 
outlined by the Research Committee on 
the Ethical Use of Animals (UiTM Care: 
159/2016). In this study, female Mus 
musculus mice aged (i) six weeks old 
(Young) with an average body weight 
of 14.8-9.7 g and (ii) six months old 
(Aging) with an average body weight 
of 26-30 g were used for experiments. 
According to Dutta & Sengupta (2016), 
six weeks old mice are equivalent to 
18-24-years of human age whereas 
six-months mice are equivalent to 
35-40-years of human age. Thus, the 
aging group in this study is defined as 
mature adult mice that are undergoing 
the aging process but have not reached 
the aged category yet. The mice 
were divided into two main groups, 
a control group and an experimental 
group, which consisted of eight mice 
per group (n=8). Mice at the age of 6 
weeks (Young group) (Group A) were 
used as a negative control group, 
while mice at the age of 6 months 
were used as a positive control group 
(Group B1). In the vehicle control 
group (Group B2), mice were given 
0.1 ml tocopherol-stripped corn oil as 
a vehicle control daily for two months 
using the force-feeding technique 
(oral gavage). The tocopherol-stripped 
corn oil that was used in this study is 
crude oil without the addition of any 
antioxidants (MP Biomedicals, USA). 
In the experimental group, 6 months 
old mice were supplemented daily 
using the force-feeding technique 
(oral gavage) for 2 months with 0.1 
ml TRF at the dose of 90 mg/kg BW 
(Group C1), 120 mg/kg BW (Group 
C2), and 150 mg/kg BW (Group C3), 
respectively. The TRF dose used in this 
study is the optimum dosage obtained 
from previous studies on the effect of 
TRF supplementation in aging mice 
on the quality of embryo (Norerlyda et 
al. 2015). The animals were housed at 
27˚C under 12-hour light-dark cycles. 
The mice were given food pellets and 
water ad-libitum daily.
Collection of Oocytes
After 2 months, all mice from 
aging (Group B1), vehicle control 
(Group B2), and TRF supplemented 
groups (Group C1, C2 and C3) were 
superovulated to synchronize the time 
for collection of oocytes. Female mice 
were superovulated intraperitoneally 
with 5 IU of pregnant mare serum 
gonadotropin (PMSG) (Sigma, Aldrich), 
followed by 5 IU of human chorionic 
gonadotropin (hCG) (Sigma, Aldrich) 
48 hours later. Subsequently, 14 
hours after hCG injection, the mice 
were euthanised and oocytes were 
collected by tearing the ampullae 
from the oviduct. The cumulus cells 
from oocytes were removed using 
hyaluronidase (Sigma, Aldrich) and 
oocytes were kept in the M2 medium 
until further analysis. M2 medium is a 
modified Krebs-Ringer solution with 
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some of the bicarbonate substituted 
with HEPES buffer to maintain the 
correct pH and this medium was used 
for collecting and keeping the embryo 
(Nagy et al. 2003). The numbers 
of normal and abnormal oocytes 
were counted and recorded. The 
morphology of normal and abnormal 
oocytes retrieved from young and 
aging mice is shown in Figure 1.  
Collection of Ovaries for 
Metabolomic Analysis
For metabolomic analysis, ovaries 
were collected from the Young 
(Group A), Aging (Group B1), vehicle 
control (Group B2), and TRF 150 mg/
kg supplemented group (Group C3). 
Ovarian samples for metabolomic 
analysis was selected only from the 
group supplemented with TRF 150 mg/
kg (Group C3) as the TRF 150 mg/kg 
supplemented group showed the best 
results for oocytes quality. The mice 
were humanely sacrificed and the 
ovaries were collected. Ovarian tissues 
were perfused with phosphate buffer 
saline (PBS). Samples were snap-frozen 
in Eppendorf tubes in liquid nitrogen 
and stored at -80˚C until processing. 
For processing, frozen samples were 
weighed around 50 mg then pulverized 
to a fine powder (freeze fracturing) 
with a mortar and pestle in liquid 
nitrogen. Metabolites were extracted 
using the mixture of chloroform: 
methanol: deionized water with the 
ratio of 2:2:1 (v/v). Approximately 
200 μl of chloroform was added to 
each sample together with 200 μl of 
methanol and 100 μl of deionized 
Figure 1: The photomicrograph of normal and abnormal morphology in oocytes retrieved from 
young and aging mice (100x magnification). (i) oocyte with normal morphology: with the presence 
of a polar body and evenly-sized zona pellucida (ii - v) oocytes with abnormal morphology: with 
the uneven size of zona pellucida, the appearance of one or multiple vacuoles, and a fragmented 
polar body.  
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water. Samples were vortexed briefly 
before centrifugation at 10,000 x g 
for 10 minutes at 4˚C. Portions of the 
aqueous layer and a portion of the 
organic layer were removed and pooled 
together in a new microcentrifuge 
tube. Supernatants were dried using 
a vacuum concentrator. All extracted 
samples were stored at -80˚C until 
required.
LC-MS Q-TOF Analysis
The chromatography, separation 
and detection of small molecules 
were performed on an Agilent Series 
1200 SL Rapid Resolution Liquid 
Chromatography system coupled 
to an Agilent 6520 accurate mass 
spectrometer equipped with dual 
electrospray ionization (ESI) source. 
For the detection of molecules, 
Zobrax Eclipse Plus C18-ID of 1.8 
μm particle size and 2.1 x 100 mm 
column dimensions were used. The 
temperature was maintained at 40˚C 
during the run. The mobile phase 
composed of (A) 0.1% formic acid 
in water and (B) 0.1% formic acid in 
acetonitrile. The flow rate was set at 
0.25 ml/minutes and the injection 
volume was 2 μl. A linear gradient was 
developed over 36 minutes from 5% 
to 95% of the mobile phase (B). The 
total run time was set at 48 minutes 
for each analysis. To produce ion 
for detection, ESI source settings 
were used as follows: V Cap 4000 V, 
skimmer 65 V and fragmentor 125 V. 
Mass spectral acquisition range was 
set from 50 to 1400 m/z. The nebulizer 
was set at 45 psig and the nitrogen 
drying gas was set at a flow rate of 
12 L/minutes. Drying gas temperature 
was maintained at 350˚C. Data were 
acquired at a rate of 2.5 spectra/second 
with a stored mass range of m/z 50-
1000. Internal reference ions were 
used to correct mass accuracy. Auto 
calibration parameters were chosen 
to average 5 scans and reference mass 
correction was enabled throughout the 
run. The mass spectrometer was tuned 
to allow the detection of compounds 
to an accuracy of + 2 ppm before the 
analysis. To assure the desired mass 
accuracy, internal reference ions (m/z 
121.0509 and 922.0098) were used 
throughout the run.
Data Processing 
MassHunter Workstation software, 
including Qualitative Analysis (version 
3.01) was used for processing both 
raw MS and MS/MS data, including 
molecular feature extraction, 
background subtraction and data 
filtering. To perform subtraction of 
molecular features (MFs) originating 
from the background, analysis of a blank 
sample (deionized water) was carried 
out under identical instrument settings 
and background MFs were removed. 
Using background-subtracted data, 
files in compound exchange format 
(CEF files) were created for each 
sample and exported into the Mass 
Profiler Professional (MPP) software 
package for further processing. 
 To minimize the number of missing 
values, only metabolites that were 
consistently detected in at least 50% of 
samples were included in the statistical 
analyses (Xia & Warshart 2016). All 
known artifact peaks, such as internal 
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standards, column bleed, plasticizers, 
or reagent peaks were excluded from 
the result sheets. All metabolite data 
were normalized relative to the sum 
of all known metabolites in each 
sample and were log transformed. 
The metabolites were detected using 
the Mass Profiler Professional (MPP) 
software package and were identified 
based on the Kyoto Encyclopedia 
of Genes and Genomes (KEGG) 
database. The identified metabolites 
were used to check on their associated 
pathways in the KEGG database and 
the metabolite enrichment analysis 
was analyzed using MetaboAnalyst. 
Statistical Analysis
For oocyte quality, the significant 
differences between groups were 
analyzed using the Chi-Square Test and 
considered significant at p<0.05. The 
data were analyzed using Statistical 
Package for Social Science (SPSS) 
version 25 and data were expressed as 
a percentage.
 For metabolomic analysis, Mass 
Profiler Professional (version B.02.00) 
was used for statistical analysis by 
Analysis of One-way Analysis of 
Variance (ANOVA) and Partial Least 
Squares-Discriminant Analysis (PLS-
DA), followed by the construction of 
the predictive classification model, 
molecular formula estimation, and 
database searching.
RESULTS AND DISCUSSION
In this study, the quality of oocytes was 
evaluated based on the morphology of 
normal and abnormal oocytes, which 
were observed using an inverted 
microscope (Figure 1). Oocytes with 
the presence of a polar body and 
evenly sized zona pellucida are defined 
as normal oocytes. Meanwhile, the 
oocytes with no polar body or uneven 
size of zona pellucida, the appearance 
of one or multiple vacuoles and 
fragmented polar body are defined as 
abnormal oocytes. Figure 2 shows a 
lower percentage of normal oocytes in 
Figure 2: The quality of oocytes retrieved from young and aging mice. The percentage of normal 
oocytes was significantly lower (p<0.001) and the abnormal oocytes were significantly higher in 
percentage (p<0.001) in the aging group when compared to the young group. Values were expressed 
as a percentage. Data were analysed using Chi-square test. ***p<0.001 significant difference from 
the Young group, n = 8
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Figure 3: The quality of oocytes retrieved from aging mice supplemented with TRF. The percentage 
of normal oocytes in the group supplemented with TRF 150 mg/kg BW was significantly higher 
(p<0.05) and the abnormal oocytes were significantly lower (p<0.05) when compared to vehicle 
control and the other TRF Groups. Values were expressed as a percentage. Data were analysed using 
Chi-square test. *p<0.05, **p<0.01 significant difference from the vehicle control group, ##p<0.01 
significant difference from the other TRF groups, #p<0.05 significant difference from the other TRF 
groups, n = 8.
Figure 4: PLS-DA Score plot between Young and Aging groups. The explained variances are shown 
in brackets. Ovarian metabolomics profiles examined by supervised PLS-DA demonstrated a 
clear differentiation between the Young and Aging groups. Plots show Component 1 (x-axis) and 
Component 2 (y-axis) with the percentage of the variance explained by each component labelled 
on the axis. Ovals indicate the 95% confidence interval (p<0.05). Discrimination of metabolite 
regulation is presented as fold change between the Young and Aging groups.
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aging (p<0.001) as compared to Young 
group, while in Figure 3, the percentage 
of normal oocytes in aging mice 
supplemented with TRF at 150 mg/kg 
BW was found to be higher (p<0.01) as 
compared to the vehicle control group. 
The percentage of normal oocytes in 
aging mice supplemented with TRF 
at 150 mg/kg BW was found to be 
significantly higher as compared to 
other TRF-supplemented groups.
 Using non-targeted metabolomics 
analysis, thousands of metabolite 
signals were captured whereby 17 
metabolites were identified to be 
significantly different in ovarian tissue 
of the aging group when compared to 
the Young group (Table 1). Meanwhile, 
14 metabolites were identified to be 
significantly different in the ovarian 
tissue of vehicle control and TRF 
supplemented groups (Table 2). Ovarian 
metabolomics profiles examined by 
supervised PLS-DA demonstrated 
a clear differentiation between 
the Young and Aging groups. This 
differentiation was mainly described 
along with the first component of the 
PLS-DA. Discrimination of metabolites 
regulation was presented in fold-
change in Young and Aging groups as 
shown in Figure 4, where metabolites 
in the young group were found to be 
down regulated.
 The aging process affects ovarian 
function causing ovarian failure that 
may lead to a decrease in the number 
of follicles, loss of follicular functions, 
a decline in oocyte reserve as well 
as oocyte quality (Sukur et al. 2014). 
This finding indicates that oxidative 
stress-induced ovarian aging results 
Metabolites Regulation Log Fold Change p-value
Prostaglandin A2 Up 3.2969 3.77E-05
17alpha-Hydroxypregnenolone Up 1.0654542 9.05E-05
Retinoate Up 6.5015 0.0001745
Spermine Up 7.252243 0.0005523
alpha-Linolenic acid Up 7.2743425 0.0009626
Thymidine Up 5.5446 0.0010138
Taurocholic acid Up 3.8329222 0.0015217
S-Acetyldihydrolipoamide-E Down -4.6399693 0.0015635
17alpha-Hydroxyprogesterone Up 5.4235144 0.0016782
Cholic acid Up 6.4932 0.002076
N-Acetylornithine Up 6.4932 0.002076
5-Hydroxykynurenamine Up 6.2964 0.0020764
Hypoxanthine Down -6.7602 0.0020765
Linoleic acid Down -6.3692 0.0020772
UDP-N-acetyl-alpha-D-glucosamine Down -6.113 0.0021012
3-Dehydrosphinganine Up 4.6620464 0.002138
Prostaglandin D2 Up 5.1589217 0.0028375
Table 1: The differential metabolites in the ovary between the Young and Aging groups
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in the dysfunction of the reproductive 
process (Fujii et al. 2005). Based on 
Figure 2, the loss of oocyte quality 
in aging is believed to be due to an 
increase in meiotic non-disjunction, 
thus resulting in dysfunction of the 
reproductive process (Broekmans et al. 
2009). Using metabolomics analysis, it 
was shown that metabolic dysfunction 
is a common hallmark of the aging 
process (Houtkooper et al. 2011). 
 TRF supplementation has been 
previously shown to improve the 
quality of oocytes in aging mice by 
lowering the percentage of oxidative 
deoxyribonucleic acid (DNA) damage, 
thereby restoring the telomere length 
and telomerase activity. Consequently, 
mitochondrial function is protected 
during oxidative stress conditions 
(Hamdan et al. 2017). Therefore, the 
results of this study confirm that aging 
is highly correlated with oxidative 
stress in the ovary thus leading to the 
production of poor quality oocytes. 
Metabolomic analysis from ovaries 
shows that most affected pathways are 
fatty acid and amino acid metabolism. 
The most remarkable changes in 
metabolism in Aging groups were 
defined by a significant change in fatty 
acid-related metabolism, specifically 
in alpha-linolenic acid metabolism 
(Figure 5). Previously it was reported 
that in aging, as an alternative for 
oxidative phosphorylation, fatty acid 
was utilized for ATP production (Fong 
et al. 2011). Accumulation of fatty acids 
intermediates in the cardiomyocyte 
cytosol could result in lipotoxicity and 
could result in a decrease in fertility 
(Wu et al. 2000). 
 Meanwhile, ovarian metabolomic 
profiles when compared between 
the vehicle control group and TRF 
supplemented group (examined by 
supervised PLS-DA) demonstrated 
a clear differentiation between both 
Metabolites Regulation Log Fold Change p-value
Androsterone glucuronide Down -7.2097 0.000103
Alpha-Linolenic acid Down -4.3562 0.000345
Resiniferatoxin Down -7.9118 0.000388
5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid  Down -1.2582 0.000471
R-S-Lactoylglutathione Up 4.6552 0.000821
S-Acetyldihydrolipoamide-E Up 7.3555 0.002078
Nicotinamide adenine dinucleotide Up 6.5757 0.002303
Urocanate Up 2.7953 0.003983
gamma-Glutamyl-gamma-aminobutyraldehyde Up 6.5958 0.004213
17-Hydroxylinolenic acid Down -7.4267 0.004528
Arachidonic acid Up 6.8773 0.004552
Docosahexaenoic acid Down -3.5048 0.005002
beta-D-Glucuronoside Down -2.9536 0.005562
11-Deoxycorticosterone Up 2.7811 0.005917
Table 2: The differential metabolites in the ovary between vehicle control and TRF-
supplemented group
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groups (Figure 6). This differentiation 
was mainly described along with 
the first component of the PLS-
DA. Discrimination of metabolites 
regulation was presented as fold-
change in vehicle control and TRF 
supplemented groups as shown in 
Figure 5, where metabolites in the 
young group were found to be down 
regulated. TRF-supplemented group 
showed a significant down-regulation 
in alpha-linolenic acid metabolism. 
Alpha-linolenic acid metabolism is 
important and needs to be provided 
in the diet. Alpha-linolenic acid is 
necessary for numerous processes, 
including growth, reproduction, 
improved reproductive lifespan, oocyte 
quality and aging (Dunning et al. 
2014). However, the imbalance of fatty 
acids (FAs) in cell membranes where 
the metabolism is highly regulated 
can cause damage from free radicals 
leading to oxidative stress (Tsaluchidu 
et al. 2008). Furthermore, fatty acids 
are used as an energy source during 
oocyte maturation and the extended 
period of embryo development before 
implantation (Wathes et al. 2007).
 In the Aging group, amino 
acid metabolism was mostly up-
regulated (Figure 6) (Table 1). These 
findings suggest that due to oxidative 
stress, amino acid metabolism was 
upregulated, causing damage to cell 
structures leading to low viability of 
Figure 5: Results of metabolite set enrichment analysis (MSEA) in Young vs Aging group. The 
horizontal bar graph summarizes the metabolic pathways that were strongly affected in the Aging 
group compared to the Young group. Metabolite sets are ranked according to Holm p-value with 
hatched lines showing the cut off Holm p-value. The bars are colored based on their p-values and 
the length is based on the fold enrichment.
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cells (Fujii et al. 2005). An increase 
regulation of most amino acid 
metabolism in the ovary of the aging 
group, as was found in the present 
study. This could result from an 
increase in the rate of a whole-body 
protein breakdown, insulin resistance 
and subsequent oxidation of their 
carbon skeletons in the citric acid 
cycle (Lawton et al. 2008).
 However, a significant down-
regulation in amino acid metabolism 
was observed in the TRF-supplemented 
group (Figure 7) (Table 2). This finding 
is comparable to that reported by 
Botros et al. (2008), which found that 
embryos with TRF viability had a lower 
amino acid metabolism needed for 
successful implantation than did the 
embryos that were arrested. Although 
the metabolism of amino acids on 
ovarian function and aging is still not 
well understood, a recent study on the 
metabolic profiles of ovarian follicular 
fluid collected from patients undergoing 
in vitro fertilization (IVF) revealed that 
women with repeated IVF failure had 
increased concentrations of amino 
acids (Xia et al. 2014). Interestingly, 
the process was reversed in the 
TRF-supplemented group by down 
regulation of amino acid metabolism, 
thus suggesting the effectiveness of 
TRF in combating oxidative stress 
and enhancing antioxidant defence 
mechanisms. This was in accordance 
Figure 6: PLS-DA Score plot between vehicle control and TRF 150 groups. The explained 
variances are shown in brackets. Ovarian metabolomics profiles examined by supervised PLS-DA 
demonstrate a clear differentiation between vehicle control and TRF-supplemented group. Plots 
show Component 1 (x-axis) and Component 2 (y-axis) with the percentage of the variance explained 
by each component labelled on the axis. Ovals indicate the 95% confidence interval (p<0.05). 
Discrimination of metabolites regulation was presented as fold change between vehicle control and 
TRF-supplemented groups.
67
TRF Improves Oocyte Quality Med & Health Jun 2020;15(1): 54-69
with the study of Khor et al. (2017) 
where oxidative stress affects the 
normal function of satellite cells, with 
subsequent regeneration defects that 
lead to sarcopenia. This study aimed 
to evaluate TRF, where they found 
similar outcomes in senescent human 
myoblast tissue supplemented with 
TRF.
CONCLUSION
In conclusion, TRF supplementation at 
a dose of 150 mg/kg body weight (BW) 
for two months was effective in delaying 
the effect of aging on oocyte quality. 
Additionally, metabolic changes in 
the aging ovary had a negative impact 
on cellular energy storage, energy 
metabolism and oxidative stress that 
subsequently affects female fertility. 
Furthermore, supplementation with 
TRF prevented the negative impact 
of age-related metabolic changes in 
the ovary. Thus, TRF is proposed to 
exert a protective effect on female 
reproductive aging. The pathways 
identified also suggest a positive 
relationship between metabolic 
changes in the ovary and the quality 
of oocytes in mice supplemented with 
TRF.
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